Pancreatic Cancer Research

Journal articlePancreatology2019

Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.

Journal
Pancreatology
Published
24 October 2018
Citations
90
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Background Pancreatic exocrine insufficiency (PEI) and malnutrition are prevalent among patients with pancreatic adenocarcinoma. Pancreatic enzyme replacement therapy (PERT) can correct PEI but its use among patients with pancreatic cancer is unclear as are effects upon survival. … Excerpt only: this text is the publisher’s. Read it in full at the source.